RecruitingPhase 4NCT06268704

Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection

Particulate Versus Non-Particulate Corticosteroid in Sacroiliac Joint Injection: A Randomized Prospective Study


Sponsor

University of New Mexico

Enrollment

230 participants

Start Date

Mar 27, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study will compare two different corticosteroids (dexamethasone and methylprednisolone) for use in sacroiliac joint injections to treat SI joint pain.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called 2% Lidocaine HCl Injection, a drug called Dexamethasone, and others for people with sacro-iliac spondylosis and sacroiliac joint dysfunction. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 99 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexamethasone

This is a non-particulate steroid commonly used to treat SI joint pain.

DRUGMethylprednisolone

This is a particulate steroid commonly used to treat SI joint pain.

DRUG2% Lidocaine HCl Injection

Lidocaine is a local anesthetic used in SI joint injection procedures to numb the procedure site and helps to confirm SI joint dysfunction when injected with the steroid medication into the SI joint.


Locations(1)

University of New Mexico Hospital

Albuquerque, New Mexico, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06268704


Related Trials